Bioequivalence of immediate-release theo
โ
Marvin C. Meyer; Eric J. Jarvi; Arthur B. Straughn; Francis R. Pelsor; Roger L.
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 112 KB
A three-way crossover study in 18 healthy male volunteers was conducted to evaluate the bioequivalence of three different 200 mg anhydrous theophylline immediate-release (IR) capsules. The products had not been rated as therapeutically equivalent by the US Food and Drug Administration (FDA) owing to